Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Cash Flow Reinvestment Rate
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Cash Flow Reinvestment Rate of 0.73x as of September 2025, reinvesting CN¥292.24 Million (capex CN¥292.24 Million ) from operating cash flow of CN¥400.70 Million. Check Shenzhen Salubris Pharmaceuticals Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shenzhen Salubris Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Explore Shenzhen Salubris Pharmaceuticals Co Ltd (002294) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Year-by-year capital reinvestment analysis for Shenzhen Salubris Pharmaceuticals Co Ltd. For live market cap and broader valuation context, see how much is Shenzhen Salubris Pharmaceuticals Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.29x | CN¥1.53 Billion | CN¥1.19 Billion | CN¥624.81 Million | ▼ -45.2% |
| 2023 | 2.35x | CN¥2.04 Billion | CN¥869.79 Million | CN¥671.00 Million | ▲ +77.9% |
| 2022 | 1.32x | CN¥1.28 Billion | CN¥970.80 Million | CN¥598.96 Million | ▲ +171.4% |
| 2021 | 0.49x | CN¥576.03 Million | CN¥1.18 Billion | CN¥482.50 Million | ▼ -23.0% |
| 2020 | 0.63x | CN¥867.50 Million | CN¥1.37 Billion | CN¥642.47 Million | ▲ +39.8% |
| 2019 | 0.45x | CN¥680.11 Million | CN¥1.51 Billion | CN¥457.19 Million | ▼ -19.3% |
| 2018 | 0.56x | CN¥749.80 Million | CN¥1.34 Billion | CN¥332.87 Million | ▼ -33.3% |
| 2017 | 0.84x | CN¥1.22 Billion | CN¥1.46 Billion | CN¥331.67 Million | ▲ +55.1% |
| 2016 | 0.54x | CN¥775.06 Million | CN¥1.43 Billion | CN¥245.06 Million | ▲ +33.7% |
| 2015 | 0.40x | CN¥426.57 Million | CN¥1.06 Billion | CN¥235.57 Million | ▲ +97.7% |
| 2014 | 0.20x | CN¥200.65 Million | CN¥982.25 Million | CN¥200.65 Million | ▼ -68.0% |
| 2013 | 0.64x | CN¥427.20 Million | CN¥668.52 Million | CN¥427.20 Million | ▲ +16.2% |
| 2012 | 0.55x | CN¥286.75 Million | CN¥521.21 Million | CN¥286.75 Million | ▼ -40.7% |
| 2011 | 0.93x | CN¥252.60 Million | CN¥272.32 Million | CN¥252.60 Million | ▼ -22.5% |
| 2010 | 1.20x | CN¥223.48 Million | CN¥186.65 Million | CN¥223.48 Million | ▲ +18.5% |
| 2009 | 1.01x | CN¥135.68 Million | CN¥134.28 Million | CN¥135.68 Million | ▲ +28.0% |
| 2008 | 0.79x | CN¥61.48 Million | CN¥77.89 Million | CN¥61.48 Million | ▲ +203.8% |
| 2007 | 0.26x | CN¥13.71 Million | CN¥52.75 Million | CN¥13.71 Million | ▼ -67.9% |
| 2006 | 0.81x | CN¥9.71 Million | CN¥12.00 Million | CN¥9.71 Million | — |